1-3 of 3
Sarah E. M. Herman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TLR Signaling Is Activated in Lymph Node–Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib

Eman L. Dadashian, Erin M. McAuley, Delong Liu, Arthur L. Shaffer, III, Ryan M. Young, Jessica R. Iyer, Michael J. Kruhlak, Louis M. Staudt, Adrian Wiestner, Sarah E. M. Herman
Journal: Cancer Research
Cancer Res (2019) 79 (2): 360–371.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-0781
Published: 15 January 2019
View article
PDF
Includes: Supplementary data
Journal Articles

MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia

Nakhle S. Saba, Deanna H. Wong, Georges Tanios, Jessica R. Iyer, Patricia Lobelle-Rich, Eman L. Dadashian, Delong Liu, Lorena Fontan, Erik K. Flemington, Cydney M. Nichols, Chingiz Underbayev, Hana Safah, Ari Melnick, Adrian Wiestner, Sarah E. M. Herman
Journal: Cancer Research
Cancer Res (2017) 77 (24): 7038–7048.
DOI: https://doi.org/10.1158/0008-5472.CAN-17-2485
Published: 14 December 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 2624: The novel Bruton's tyrosine kinase inhibitor ACP-196 shows in vivo efficacy against human chronic lymphocytic leukemia cells xenografted to the NSG mouse model

Carsten U. Niemann, Arnau Montraveta, Sarah E. M. Herman, Tim Ingallinera, Tjeerd Barf, Dolors Colomer, Adrian Wiestner
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2624.
DOI: https://doi.org/10.1158/1538-7445.AM2014-2624
Published: 01 October 2014
View article